ITRM930356A0 - Uso di esteri sull'ossidrile della l-carnitina per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee. - Google Patents
Uso di esteri sull'ossidrile della l-carnitina per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee.Info
- Publication number
- ITRM930356A0 ITRM930356A0 IT93RM356A ITRM930356A ITRM930356A0 IT RM930356 A0 ITRM930356 A0 IT RM930356A0 IT 93RM356 A IT93RM356 A IT 93RM356A IT RM930356 A ITRM930356 A IT RM930356A IT RM930356 A0 ITRM930356 A0 IT RM930356A0
- Authority
- IT
- Italy
- Prior art keywords
- carnitine
- hydroxyl
- esters
- treatment
- pharmaceutical compositions
- Prior art date
Links
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 title 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 208000017520 skin disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/006—Antidandruff preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Birds (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITRM930356A IT1261688B (it) | 1993-05-28 | 1993-05-28 | Uso di esteri sull'ossidrile della l-carnitina per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee. |
AT94108015T ATE177947T1 (de) | 1993-05-28 | 1994-05-25 | Verwendung von l-carnitin-o-estern zur behandlung der dermatosen |
DE69417290T DE69417290T2 (de) | 1993-05-28 | 1994-05-25 | Verwendung von L-Carnitin-O-Estern zur Behandlung der Dermatosen |
DK94108015T DK0628309T3 (da) | 1993-05-28 | 1994-05-25 | Anvendelse af O-estere af L-carnitin til behandling af dermatoser |
EP94108015A EP0628309B1 (en) | 1993-05-28 | 1994-05-25 | Use of O-esters of L-carnitine for the treatment of dermatoses |
ES94108015T ES2130304T3 (es) | 1993-05-28 | 1994-05-25 | Empleo de o-esteres de l-carnitina para el tratamiento de dermatosis. |
ZA943727A ZA943727B (en) | 1993-05-28 | 1994-05-26 | Use of o-esters of l-carnitine for producing pharmaceutical compositions for the reatment of dermatoses |
CA002124402A CA2124402A1 (en) | 1993-05-28 | 1994-05-26 | Use of o-esters of l-carnitine for producing pharmaceutical compositions for the treatment of dermatoses |
US08/250,686 US5494924A (en) | 1993-05-28 | 1994-05-27 | Therapeutical method for the treatment of dermatoses using O-esters of L-carnitine |
JP6115025A JPH0748328A (ja) | 1993-05-28 | 1994-05-27 | L−カルニチンのo−エステル類を含む皮膚病処置のための医薬組成物 |
TW083105639A TW288976B (it) | 1993-05-28 | 1994-06-20 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITRM930356A IT1261688B (it) | 1993-05-28 | 1993-05-28 | Uso di esteri sull'ossidrile della l-carnitina per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee. |
Publications (3)
Publication Number | Publication Date |
---|---|
ITRM930356A0 true ITRM930356A0 (it) | 1993-05-28 |
ITRM930356A1 ITRM930356A1 (it) | 1994-11-28 |
IT1261688B IT1261688B (it) | 1996-05-29 |
Family
ID=11401786
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITRM930356A IT1261688B (it) | 1993-05-28 | 1993-05-28 | Uso di esteri sull'ossidrile della l-carnitina per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee. |
Country Status (11)
Country | Link |
---|---|
US (1) | US5494924A (it) |
EP (1) | EP0628309B1 (it) |
JP (1) | JPH0748328A (it) |
AT (1) | ATE177947T1 (it) |
CA (1) | CA2124402A1 (it) |
DE (1) | DE69417290T2 (it) |
DK (1) | DK0628309T3 (it) |
ES (1) | ES2130304T3 (it) |
IT (1) | IT1261688B (it) |
TW (1) | TW288976B (it) |
ZA (1) | ZA943727B (it) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1276253B1 (it) | 1995-12-15 | 1997-10-27 | Sigma Tau Ind Farmaceuti | Composizione farmaceutica contenente l-carnitina o alcanoil l-carnitine per la prevenzione ed il trattamento di stati morbosi |
US5667791A (en) * | 1996-05-31 | 1997-09-16 | Thione International, Inc. | X-ray induced skin damage protective composition |
EP0946485A4 (en) | 1996-11-12 | 2000-01-19 | Tamarkin Pharmaceutical Innova | METHOD FOR TREATING DERMATOLOGICAL DISEASES |
IT1291113B1 (it) * | 1997-03-20 | 1998-12-29 | Sigma Tau Ind Farmaceuti | Composizione nutritiva terapeutica per soggetti affetti da diabete mellito |
IT1291126B1 (it) * | 1997-04-01 | 1998-12-29 | Sigma Tau Ind Farmaceuti | Composizioni solide atte alla somministrazione orale comprendenti sali non igroscopici della l-carnitina e delle alcanoil l-carnitine |
IT1291133B1 (it) * | 1997-04-07 | 1998-12-29 | Sigma Tau Ind Farmaceuti | Composizioni solide atte alla somministrazione orale comprendenti l-carnitina e alcanoil l-carnitine magnesio tartrato |
IT1291134B1 (it) * | 1997-04-08 | 1998-12-29 | Sigma Tau Ind Farmaceuti | Composizioni solide atte alla somministrazione orale comprendenti una alcanoil l-carnitina magnesio citrato |
IT1291143B1 (it) * | 1997-04-18 | 1998-12-29 | Sigma Tau Ind Farmaceuti | Composizioni solide atte alla somministrazione orale comprendenti l-carnitina colina tartrato o una alcanoil l-carnitina colina |
IT1290600B1 (it) * | 1997-04-30 | 1998-12-10 | Sigma Tau Ind Farmaceuti | Composizioni solide atte alla somministrazione orale comprendenti l-carnitina e alcanoil l-carnitine magnesio fumarato |
US6138683A (en) * | 1997-09-19 | 2000-10-31 | Thione International, Inc. | Smokeless tobacco products containing antioxidants |
US5922346A (en) * | 1997-12-01 | 1999-07-13 | Thione International, Inc. | Antioxidant preparation |
US5863940A (en) | 1997-12-01 | 1999-01-26 | Sigma-Tau Healthscience S.P.A. | Medicament and therapeutical method for treating idiopathic asthenozoospermia |
US6090848A (en) * | 1997-12-01 | 2000-07-18 | Sigma-Tau Healthscience S.P.A. | Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans |
SI0951909T2 (sl) | 1998-03-19 | 2010-11-30 | Sigma Tau Ind Farmaceuti | Kombinirana zmes ki vsebuje L karnitin ali alkanoil L karnitin glikozaminoglikan in ali njegov sestavni del |
US6242491B1 (en) * | 1999-06-25 | 2001-06-05 | Rima Kaddurah-Daouk | Use of creatine or creatine compounds for skin preservation |
US20040198821A1 (en) * | 2002-01-29 | 2004-10-07 | Hwang Cheng Shine | Reduction of hair growth |
CA2436650A1 (en) * | 2003-08-06 | 2005-02-06 | Naturia Inc. | Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses |
CN1960698A (zh) * | 2004-05-31 | 2007-05-09 | 昭和电工株式会社 | 含肉碱衍生物的局部减肥制剂和化妆品 |
ES2336995B1 (es) | 2008-10-13 | 2011-02-09 | Lipotec, S.A. | Composicion cosmetica o dermofarmaceutica para el cuidado de la piel,cuero cabelludo y uñas. |
US9259343B2 (en) | 2012-07-06 | 2016-02-16 | Newman Technologies LLC | Device for mitigating plantar fasciitis |
US20140316156A1 (en) * | 2013-04-18 | 2014-10-23 | Deborah Warner | Method of producing therapeutic agent |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1156840B (it) * | 1978-06-27 | 1987-02-04 | Sigma Tau Ind Farmaceuti | Acil derivati della carnitina |
IT1116037B (it) * | 1979-04-23 | 1986-02-10 | Sigma Tau Ind Farmaceuti | Esteri e ammidi di acil carnitine loro procedimenti di preparazione e loro uso terapeutico |
FR2654619B1 (fr) * | 1989-11-23 | 1992-01-31 | Sederma Sa | Utilisation en cosmetique de composes destines a optimiser la penetration des principes actifs. |
IT1263013B (it) * | 1992-10-20 | 1996-07-23 | Avantgarde Spa | Esteri della l-carnitina e di alcanoil l-carnitine con l'acido glicolico o suoi esteri e composizioni farmaceutiche contenenti tali per il trattamento di affezioni cutanee. |
-
1993
- 1993-05-28 IT ITRM930356A patent/IT1261688B/it active IP Right Grant
-
1994
- 1994-05-25 DK DK94108015T patent/DK0628309T3/da active
- 1994-05-25 ES ES94108015T patent/ES2130304T3/es not_active Expired - Lifetime
- 1994-05-25 DE DE69417290T patent/DE69417290T2/de not_active Expired - Fee Related
- 1994-05-25 EP EP94108015A patent/EP0628309B1/en not_active Expired - Lifetime
- 1994-05-25 AT AT94108015T patent/ATE177947T1/de not_active IP Right Cessation
- 1994-05-26 ZA ZA943727A patent/ZA943727B/xx unknown
- 1994-05-26 CA CA002124402A patent/CA2124402A1/en not_active Abandoned
- 1994-05-27 JP JP6115025A patent/JPH0748328A/ja active Pending
- 1994-05-27 US US08/250,686 patent/US5494924A/en not_active Expired - Fee Related
- 1994-06-20 TW TW083105639A patent/TW288976B/zh active
Also Published As
Publication number | Publication date |
---|---|
EP0628309B1 (en) | 1999-03-24 |
TW288976B (it) | 1996-10-21 |
JPH0748328A (ja) | 1995-02-21 |
CA2124402A1 (en) | 1994-11-29 |
ZA943727B (en) | 1995-02-02 |
DE69417290D1 (de) | 1999-04-29 |
DK0628309T3 (da) | 1999-10-11 |
ES2130304T3 (es) | 1999-07-01 |
ITRM930356A1 (it) | 1994-11-28 |
DE69417290T2 (de) | 1999-08-19 |
IT1261688B (it) | 1996-05-29 |
US5494924A (en) | 1996-02-27 |
ATE177947T1 (de) | 1999-04-15 |
EP0628309A1 (en) | 1994-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ITRM930356A0 (it) | Uso di esteri sull'ossidrile della l-carnitina per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee. | |
ITRM930399A0 (it) | Uso di esteri della l-carnitina o di acil l- carnitine con idrossiacidi per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee. | |
HUP0000558A3 (en) | Use of active d vitamin analogues for producing pharmaceutical composition for the treatment of prostatic diseases | |
ITRM920761A0 (it) | Esteri della l-carnitina e di alcanoil l-carnitine con l'acido glicolico o suoi esteri e composizioni farmaceutiche contenenti tali per il trattamento di affezioni cutanee. | |
IT1272290B (it) | Sale della l-carnitina e composizioni farmaceutiche che lo contengono per il trattamento di affezioni cutanee | |
ITRM930365A0 (it) | Uso di esteri sull'ossidrile della l-carnitina con acidi aromatici perprodurre composizioni farmaceutiche per il trattamento di affezioni cutanee. | |
HUP9904317A3 (en) | Use of 1-hydroxy-2-pyridones for producing pharmaceutical compositions suitable for the treatment of skin diseases | |
ITRM910327A0 (it) | Uso di esteri di acil l-carnitine con l'acido gamma-idrossibutirrico per produrre composizioni farmaceutiche per il trattamento di epatopatie. | |
TR199900662T2 (xx) | 1-Hidroksi-2-piridonlar�n seborik dermatit tedavisi amac�yla kullan�m� | |
IT8721115A0 (it) | Fitopreparato per la cura di affezioni cutanee. | |
IT1274157B (it) | "sale della l-carnitina e composizioni farmaceutiche che lo contengonoper il trattamento di affezioni cutanee" | |
IT9020968A0 (it) | Metodi e composizioni farmaceutiche per il trattamento di malattie oftalmiche | |
ITMI950958A0 (it) | Composizioni farmaceutiche per il trattamento della alcol-dipendenza | |
DE68908414D1 (de) | Pharmazeutische zusammensetzungen fuer die reizung eines immunostimulierenden effektes. | |
IT1204571B (it) | Esteri di 1,4:3,6-dianidrosorbitolo-2-mononitrato e 5-mononitrato,loro procedimento di preparazione e loro composizioni farmaceutiche | |
CA2075926A1 (en) | Hydroquinone amino-acid esters, method of preparation, and pharmaceutical or cosmetic compositions containing them | |
DE68905076D1 (de) | Pharmazeutische zusammensetzung fuer die behandlung von hautwunden. | |
EP0302303A3 (en) | Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation | |
ITRM950589A0 (it) | Uso di muteine di citochine naturali come immunogeni per la preparazione di composizioni farmaceutiche per curare o prevenire malattie causate dalla sovrapproduzione di dette citochine naturali, e composizioni farmaceutiche cosi' ottenibili | |
IT1248983B (it) | Procedimento per la sintesi di alfa-idrossi esteri | |
IT8821369A0 (it) | Composizione farmaceutica utile per il trattamento di malattie cardiovascolari. | |
ITMI911206A0 (it) | Formulazioni farmaceutiche per il trattamento di malattie periferiche vascolari | |
ATE92768T1 (de) | Pharmazeutische zusammensetzungen fuer die reizung eines immunostimulierenden effektes. | |
IT1231944B (it) | Composizione farmaceutica per il trattamento di protozoosi, particolarmente della tripasonomiasi comprendente d-carnitina o un alcanoilderivato della d-carnitina | |
AU1002697A (en) | Topical compositions for the treatment of skin disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
0001 | Granted | ||
TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19970418 |